Cellular iron status influences the functional relationship between microglia and oligodendrocytes

GLIA

Volumn 54, Issue 8, 2006, Pages 795-804

  Zhang, X ^a   Surguladze, N ^a   Slagle Webb, B ^a   Cozzi, A ^b   Connor, James R ^a,c  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Glia; Inflammation; Metals; Myelin disorders; Neurodegenerative diseases; Trophic factors

Indexed keywords

CYTOKINE; FERRITIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; IRON; IRON CHELATE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; HOMEOSTASIS; IN VIVO STUDY; MICROGLIA; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; TROPHIC LEVEL;

ANIMALS; ANIMALS, NEWBORN; APOFERRITINS; BRAIN; CELL COMMUNICATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; CYTOTOXINS; DOWN-REGULATION; HOMEOSTASIS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; IRON; IRON CHELATING AGENTS; MICROGLIA; MYELIN SHEATH; NF-KAPPA B; OLIGODENDROGLIA; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING;

EID: 33750535445     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20416     Document Type: Article

References (67)

1. Aarli JA. 2003. Role of cytokines in neurological disorders. Curr Med Chem 10:1931-1937.
2. Abney ER, Williams BP, Raff MC. 1983. Tracing the development of oligodendrocytes from precursor cells using monoclonal antibodies, fluorescence-activated cell sorting, and cell culture. Dev Biol 100:166-171.
3. Barres BA, Hart IK, Coles HS, Burne JF, Voyvodic JT, Richardson WD, Raff MC. 1992. Cell death and control of cell survival in the oligodendrocyte lineage. Cell 70:31-46.
4. Bartlett WP, Li XS, Connor JR. 1991. Expression of transferrin mRNA in the CNS of normal and jimpy mice. J Neurochem 57:318-322.
5. Beard JL, Wiesinger JA, Connor JR. 2003. Pre- and postweaning iron deficiency alters myelination in Sprague-Dawley rats. Dev Neurosci 25:308-315.
6. Berg D, Gerlach M, Youdim MB, Double KL, Zecca L, Riederer P, Becker G. 2001. Brain iron pathways and their relevance to Parkinson's disease. J Neurochem 79:225-236.
7. Bidmon HJ, Emde B, Oermann E, Kubitz R, Witte OW, Zilles K. 2001. Heme oxygenase-1 (HSP-32) and heme oxygenase-2 induction in neurons and glial cells of cerebral regions and its relation to iron accumulation after focal cortical photothrombosis. Exp Neurol 168:1-22.
8. Bottenstein JE, Hunter SF, Seidel M. 1988. CNS neuronal cell line-derived factors regulate gliogenesis in neonatal rat brain cultures. J Neurosci Res 20:291-303.
9. Burdo JR, Martin J, Menzies SL, Dolan KG, Romano MA, Fletcher RJ, Garrick MD, Garrick LM, Connor JR. 1999. Cellular distribution of iron in the brain of the Belgrade rat. Neuroscience 93:1189-1196.
10. Cheepsunthorn P, Palmer C, Connor JR. 1998. Cellular distribution of ferritin subunits in postnatal rat brain. J Comp Neurol 400:73-86.
11. Cheepsunthorn P, Palmer C, Menzies S, Roberts RL, Connor JR. 2001. Hypoxic/ischemic insult alters ferritin expression and myelination in neonatal rat brains. J Comp Neurol 431:382-396.
12. Connor JR. 1994. Iron acquisition and expression of iron regulatory proteins in the developing brain: Manipulation by ethanol exposure, iron deprivation, and cellular dysfunction. Dev Neurosci 16:233-247.
13. Connor JR, Menzies SL. 1996. Relationship of iron to oligodendrocytes and myelination. Glia 17:83-93.
14. Connor JR, Menzies SL, Burdo JR, Boyer PJ. 2001. Iron and iron management proteins in neurobiology. Pediatr Neurol 25:118-129.
15. Connor JR, St. Martin SM, Menzies SL, Fine RE, Mufson E. 1990. The cellular distribution of transferrin and ferritin and iron in the human nervous system. J Neurosci Res 27:595-611.
16. Connor JR, Pavlick G, Karli D, Menzies SL, Palmer C. 1995. A histochemical study of iron-positive cells in the developing rat brain. J Comp Neurol 355:111-123.
17. Cozzi A, Corsi B, Levi S, Santambrogio P, Biasiotto G, Arosio P. 2004. Analysis of the biologic functions of H- and L-ferritins in HeLa cells by transfection with siRNAs and cDNAs: Evidence for a proliferative role of L-ferritin. Blood 103:2377-2283.
18. Craelius W, Migdal MW, Luessenhop CP, Sugar A, Mihalakis I. 1982. Iron deposits surrounding multiple sclerosis plaques. Arch Pathol Lab Med 106:397-399.
19. Dickson DW, Mattiace LA, Kure K, Hutchins K, Lyman WD, Brosnan CF. 1991. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab Invest 64:135-156.
20. Diemel LT, Copelman CA, Cuzner ML. 1998. Macrophages in CNS remyelination: Friend or foe? Neurochem Res 23:341-347.
21. Dobrovolskaia MA, Vogel SN. 2002. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 4:903-914.
22. Eccleston PA, Silberberg DH. 1984. The differentiation of oligodendrocytes in a serum-free hormone-supplemented medium. Brain Res 318:1-9.
23. Erb GL, Osterbur DL, LeVine SM. 1996. The distribution of iron in the brain: A phylogenetic analysis using iron histochemistry. Brain Res Dev Brain Res 93:120-128
24. Escobar Cabrera OE, Bongarzone ER, Soto EF, Pasquini JM. 1994. Single intracerebral injection of apotransferrin in young rats induces increased myelination. Dev Neurosci 16:248-254.
25. Escobar Cabrera OE, Zakin MM, Soto EF, Pasquini JM. 1997. Single intracranial injection of apotransferrin in young rats increases the expression of specific myelin protein mRNA. J Neurosci Res 47:603-608.
26. Espinosa de los Monteros A, Kumar S, Zhao P, Huang CJ, Nazarian R, Pan T, Scully S, Chang R, de Vellis J. 1999. Transferrin is an essential factor for myelination. Neurochem Res 24:235-248.
27. Gorter JA, Mesquita AR, van Vliet EA, da Silva FH, Aronica E. 2005. Increased expression of ferritin, an iron-storage protein, in specific regions of the parahippocampal cortex of epileptic rats. Epilepsia 46:1371-1379.
28. Hill JM, Ruff MR, Weber RJ, Pert CB. 1985. Transferrin receptors in rat brain: Neuropeptide-like pattern and relationship to iron distribution. Proc Natl Acad Sci USA 82:4553-4557.
29. Hulet SW, Hess EJ, Debinski W, Arosio P, Bruce K, Powers S, Connor JR. 1999. Characterization and distribution of ferritin binding sites in the adult mouse brain. J Neurochem 72:868-874.
30. Hulet SW, Heyliger SO, Powers S, Connor JR. 2000. Oligodendrocyte progenitor cells internalize ferritin via clathrin-dependent receptor mediated endocytosis. J Neurosci Res 61:52-60.
31. Hulet SW, Menzies S, Connor JR. 2002. Ferritin binding in the developing mouse brain follows a pattern similar to myelination and is unaffected by the jimpy mutation. Dev Neurosci 24:208-213.
32. Hulet SW, Powers S, Connor JR. 1999. Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains. J Neurol Sci 165:48-55.
33. Kreutzberg GW. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
34. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, Rosenberg PA, Volpe JJ, Vartanian T. 2002. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 22:2478-2486.
35. LeVine SM. 1991. Oligodendrocytes and myelin sheaths in normal, quaking and shiverer brains are enriched in iron. J Neurosci Res 29:413-419.
36. LeVine SM. 1997. Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res 760:298-303.
37. Marta CB, Davio C, Pasquini LA, Soto EF, Pasquini JM. 2002. Molecular mechanisms involved in the actions of apotransferrin upon the central nervous system: Role of the cytoskeleton and of second messengers. J Neurosci Res 69:488-496.
38. Marta CB, Paez P, Lopez M, Pellegrino de Iraldi A, Soto EF, Pasquini JM. 2003. Morphological changes of myelin sheaths in rats intracranially injected with apotransferrin. Neurochem Res 28:101-110.
39. McCarthy KD, de Vellis J. 1980. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
40. McRae A, Bona E, Hagberg H. 1996. Microglia-astrocyte interactions after cortisone treatment in a neonatal hypoxia-ischemia model. Brain Res Dev Brain Res 94:44-51.
41. Mehlhase J, Sandig G, Pantopoulos K, Grune T. 2005. Oxidation-induced ferritin turnover in microglial cells: Role of proteasome. Free Radic Biol Med 38:276-285
42. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. 1993. Microglial cell cytoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 151:2132-2141.
43. Morath DJ, Mayer-Proschel M. 2001. Iron modulates the differentiation of a distinct population of glial precursor cells into oligodendrocytes. Dev Biol 237:232-243.
44. Nicholas RS, Wing MG, Compston A. 2001. Nonactivated microglia promote oligodendrocyte precursor survival and maturation through the transcription factor NF-κ B. Eur J Neurosci 13:959-967.
45. Ortiz E, Pasquini JM, Thompson K, Felt B, Butkus G, Beard J, Connor JR. 2004. Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res 77:681-689.
46. Pang Y, Cai Z, Rhodes PG. 2003. Disturbance of oligodendrocyte development, hypomyelination, and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res Dev Brain Res 140:205-214.
47. Pawate S, Shen Q, Fan F, Bhat NR. 2004. Redox regulation of glial inflammatory response to lipopolysaccharide and interferon γ. J Neurosci Res 77:540-551.
48. Pedchenko TV, LeVine SM. 1998. Desferrioxamine suppresses experimental allergic encephalomyelitis induced by MBP in SJL mice. J Neuroimmunol 84:188-197.
49. Peeters C, van Bel F. 2001. Pharmacotherapeutical reduction of post-hypoxic-ischemic brain injury in the newborn. Biol Neonate 79:274-280.
50. Pocock JM, Liddle AC. 2001. Microglial signaling cascades in neurodegenerative disease. Prog Brain Res 132:555-565.
51. Qi Y, Jamindar TM, Dawson G. 1995. Hypoxia alters iron homeostasis and induces ferritin synthesis in oligodendrocytes. J Neurochem 64:2458-2464.
52. Reynolds R, Wilkin GP. 1988. Development of macroglial cells in rat cerebellum. II. An in situ immunohistochemical study of oligodendroglial lineage from precursor to mature myelinating cell. Development 102:409-425.
53. Richardson WD, Pringle NP, Wei-Ping Y, Ellen JC, Hall A. 1996. Origins and early development of oligodendrocytes. In: Jessen KR, Richardson WD, editors. Glial cell development. Oxfordshire, UK: Bios Scientific Publishers. pp 53-70.
54. Robb S, Connor J. 1998. An in vitro model of oxidative stress in primary mouse astrocytes. Brain Res 788:125-135.
55. Robb SJ, Robb-Gaspers LD, Scaduto RC Jr, Thomas AP, Connor JR. 1999. The influence of calcium and iron on cell death and mitochondrial function in oxidatively stressed astrocytes. J Neurosci Res 55:674-686.
56. Rodrigues RW, Gomide VC, Chadi G. 2001. Astroglial and microglial reaction after a partial nigrostriatal degeneration induced by the striatal injection of different doses of 6-hydroxydopamine. Int J Neurosci 109:91-126.
57. Saleh MC, Espinosa de los Monteros A, de Arriba Zerpa GA, Fontaine I, Piaud O, Djordjijevic D, Baroukh N, Garcia Otin AL, Ortiz E, Lewis S, Fiette L, Santambrogio P, Belzung C, Connor JR, de Vellis J, Pasquini JM, Zakin MM, Baron B, Guillou F. 2003. Myelination and motor coordination are increased in transferrin transgenic mice. J Neurosci Res 72:587-594.
58. Sanyal B, Polak PE, Szuchet S. 1996. Differential expression of the heavy-chain ferritin gene in non-adhered and adhered oligodendrocytes. J Neurosci Res 46:187-197.
59. Shinobu LA, Beal MF. 1997. The role of oxidative processes and metal ions in aging and Alzheimer disease. In: Connor JR, editor. Metals and oxidative damage in neurological disorders. New York: Plenum. pp 237-276.
60. Shoham S, Youdim MB. 2000. Iron involvement in neural damage and microgliosis in models of neurodegenerative diseases. Cell Mol Biol (Noisy-le-grand) 46:743-760.
61. Sorond FA, Ratan RR. 2000. Ironing-out mechanisms of neuronal injury under hypoxic-ischemic conditions and potential role of iron chelators as neuroprotective agents. Antioxid Redox Signal 2:421-436.
62. Tham CS, Lin FF, Rao TS, Yu N, Webb M. 2003. Microglial activation state and lysophospholipid acid receptor expression. Int J Dev Neurosci 21:431-443.
63. Visseren FL, Verkerk MS, van der Bruggen T, Marx JJ, van Asbeck BS, Diepersloot RJ. 2002. Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A. Eur J Clin Invest 32 (Suppl. 1):84-90.
64. Zaidi AU, Bessert DA, Ong JE, Xu H, Barks JD, Silverstein FS, Skoff RP. 2004. New oligodendrocytes are generated after neonatal hypoxic-ischemic brain injury in rodents. Glia 46:380-390.
65. Zajicek JP, Wing M, Scolding NJ, Compston DAS. 1992. Interactions between oligodendrocytes and microglia. Brain 115:1611-1631.
66. Zhang WJ, Frei B. 2003. Intracellular metal ion chelators inhibit TNFα-induced SP-1 activation and adhesion molecule expression in human aortic endothelial cells. Free Radic Biol Med 34:674-682.
67. Zhang X, Haaf M, Todorich B, Grosstephan E, Schieremberg H, Surguladze N, Connor JR. 2005. Cytokine toxicity to oligodendrocyte precursors is mediated by iron. Glia 52:199-208.